The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,957.00
Ask: 1,959.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,974.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 04th Mar 2013 07:12

Aggreko: JP Morgan takes target price from 1845p to 1870p, while reiterating a neutral rating.Anglo American: Nomura reduces target price from 1800p to 1700p and downgrades from neutral to reduce.ARM Holdings: Deutsche Bank increases target price from 400p to 445p, but still recommends selling.Atkins: Jefferies ups target price from 800p to 900p, while retaining its hold recommendation. Panmure Gordon revises target price from 630p to 780p and maintains a hold rating. Numis upgrades to add with a target price of 970p.Avocet Mining: Liberum Capital upgrades to buy.BBA Aviation: UBS raises target price from 200p to 250p and maintains a neutral rating. Citigroup ups target price from 220p to 292p reiterating a buy recommendation. Liberum Capital moves target price from 210p to 235p and keeps a hold recommendation.British American Tabacco: UBS revises target price from 3550p to 3750p and reiterates a buy recommendation. Nomura takes target price from 3880p to 3985p, while staying with its buy recommendation. Citigroup increases target price from 3785p to 40000p and still recommends buying.British Polythene Industries: Investec raises target price from 450p to 550p and reiterates a buy recommendation.Bunzl: UBS moves target price from 1000p to 1250p and upgrades to neutral.Candover Investements: Oriel Securities cuts target price from 415p to 400p maintaining a hold rating.Capita Group: Jefferies raises target price from 840p to 1010p and keeps a buy recommendation. Berenberg moves target price from 870p to 955p, while leaving its buy recommendation unaltered.Centrica: Societe Generale increases target price from 371p to 400p upgrading to buy.Croda International: Jefferies takes target price from 2300p to 2600p and leaves its hold recommendation unchanged.Debenhams: Panmure Gordon lowers target price from 112p to 104p, while staying with its hold recommendation.Dewhurst: After having had its target price under review, Cantor Fitzgerald moves it to 380p and maintains a buy recommendation.Diageo: Credit Suisse ups target price from 1900p to 1975p and retains an outperform rating.Direct Line Group: Credit Suisse shifts target price from 243p to 247p and leaves its outperform rating unchanged.Faroe Petroleum: Nomura cuts target price from 216p to 205p, while keeping its buy recommendation.GKN: Goldman Sachs raises target price from 195p to 272p and upgrades from sell to neutral.Hammerson: Jefferies increases target price from 476p to 535p, maintaining a hold recommendation. Deutsche Bank reduces target price from 580p to 560p and retains a but rating. Goldman Sachs shifts target price from 534p to to 546p, while staying with its buy recommendation.Hargreaves Services: Westhouse Securities ups target price from 927p to 984p keeping a buy recommendation.Hays: Numis revises target price from 80p to 100p and keeps a hold recommendation.Hikma Pharmaceuticals: JP Morgan increases target price from 860p to 1000p retaining an overweight rating.International Airlines Group: Credit Suisse revises target price from 259p to 295p keeping an outperform rating.Interserve: Numis moves target price from 460p to 565p and upgrades to add.Intertek Group: Goldman Sachs ups target price from 4335p to 4427p and retains a buy recommendation. Cantor Fitzgerald raises target price from 2750p to 3250p reiterating a hold rating.Kazakhmys: Deutsche Bank cuts target price from 735p to 650p and retains a hold recommendation.Kofax: Panmure Gordon shifts target price from 290p to 294p reiterating a hold recommendation.Laird: JP Morgan reduces target price from 291p to 280p and retains an overweight rating.Legal & General Group: Panmure Gordon raises target price from 154p to 190p and stays with its buy recommendation.Lloyds Banking Group: Deutsche Bank shifts target price from 66p to 64p, while staying with its buy recommendation. Exane BNP lowers target price from 63p to 60p and maintains an outperform rating. Societe Generale revises target price from 52p to 61p and reiterates a buy rating.Old Mutual: UBS ups target price from 205p to 215p, while downgrading to neutral. Deutsche Bank raises target price from 205p to 230p and leaves its buy recommendation unaltered.Publishing Technology: Westhouse Securities raises target price from 230p to 260p and retains a buy recommendation.Regus Group: Goldman Sachs restarts with a neutral rating and a target price of 130p.Rightmove: JP Morgan raises target price from 1802p to 1974p keeping an overweight rating. Canaccord Genuity increases target price from 2020p to 2170p and maintains a buy recommendation.RPS Group: Jefferies shifts target price from 280p to 285p and reiterates its buy recommendation.Sagentia Group: Westhouse Securities upgrades from add to buy with a target price of 107p. Numis takes target price from 113p to 126p keeping a buy rating.Senior: Jefferies moves target price from 236p to 268p, while its buy recommendation is kept.Spirent Communications: Goldman Sachs lowers target price from 205p to 200p keeping its buy recommendation. Panmure Gordon ups target price from 191p to 206p and reiterates a buy recommendation.St Modwen Properties: Espirito Santo ups target price from 223p to 279p and upgrades to buy.Taylor Wimpey: Deutsche Bank shifts target price from 77.70p to 83.20p reiterating a buy recommendation. JP Morgan moves target price from 78p to 81p and stays with its neutral rating. Citigroup shifts target price from 73p to 78p, while downgrading to sell.UBM: Goldman Sachs reduces target price from 910p to 870p and maintains a buy recommendation. JP Morgan ups target price from 770p to 795p keeping a neutral rating. Berenberg revises target price from 670p to 835p, while its buy rating is reiterated.Ultra Electronics: Investec puts its target price (prev.:1480p) and its hold recommendation under review.Weir Group: Investec takes target price from 2250p to 2350p, while downgrading from buy to hold.William Hill: Morgan Stanley ups target price from 410p to 460p keeping an overweight rating. JP Morgan raises target price from 410p to 510p and leaves its overweight rating unchanged.WPP Group: Nomura revises target price from 1030p to 1215p, while retaining a buy recommendation. Deutsche Bank increases target price from 1030p to 1050p and maintains a hold rating. Societe Generale takes target price from 1110p to 1210p keeping a buy rating.Xchanging: Citigroup moves target price from 120p to 150p and retains a neutral rating.
More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.